Synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from pineal gland research. Studied extensively in Soviet/Russian literature for telomere lengthening and longevity effects.
Epithalon is a synthetic tetrapeptide (four amino acids: Ala-Glu-Asp-Gly) that was developed through Soviet and Russian research programs, primarily by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology. It has been studied for telomere lengthening, longevity, circadian rhythm regulation, and immune function in aging populations.
Telomere and Longevity Research
Epithalon's most prominent research context is telomere biology. Laboratory and animal studies suggest it activates the enzyme telomerase, which can extend telomere length. Shortened telomeres are associated with cellular aging, and some researchers view telomerase activation as a potential anti-aging strategy, though this area is scientifically complex.
Pineal Gland and Circadian Research
Epithalon was originally designed based on the tetrapeptide sequence from the pineal gland protein epithalamin. Research has examined whether it can restore melatonin production and normalize circadian rhythms in aged animals and humans, where both tend to decline.
Longevity Animal Studies
Russian studies in rodents and fruit flies reported extended lifespan following Epithalon administration, with some studies showing 36% increases in maximum lifespan. These animal results have generated significant interest, though they have not been independently replicated in large Western studies.
Human Aging Studies
Russian clinical studies in elderly patients reported improvements in melatonin levels, immune markers, and some indicators of biological aging. These trials used controlled designs but have been conducted primarily within the Russian research community and not externally replicated.
Animal studies report significant lifespan extension, including up to 36% in some rodent experiments.
Laboratory studies show telomerase activation and telomere lengthening in cell cultures.
Human studies report improvements in melatonin levels and circadian function in elderly patients.
Immune function improvements reported in aging subjects in Russian clinical research.
No large independent Western randomized controlled trial data.
The research base is dominated by Russian studies from a single research group, which has not been independently replicated in large Western trials. Telomerase activation in humans is a scientifically complex area — activating telomerase indiscriminately has theoretical concerns because cancer cells also use telomerase to become immortal. The practical significance of the animal lifespan data for humans is unknown. This is a promising but unconfirmed area of research.
Every time a cell divides, the protective caps on the ends of chromosomes — called telomeres — get a little shorter. When they get too short, the cell stops dividing and eventually dies. An enzyme called telomerase can rebuild these caps, essentially resetting the cellular aging clock. Epithalon appears to activate telomerase in cell studies, potentially slowing the rate at which cells' chromosomes lose their protective caps. The peptide also seems to interact with the pineal gland, which produces melatonin and helps regulate the body's internal clock. With age, both telomerase activity and melatonin production tend to decline. Epithalon is being studied as a way to partially restore both.
In published Russian studies, Epithalon was reported as well-tolerated with no significant adverse effects. The theoretical concern with telomerase activation is the possible promotion of cancer cell survival, though published studies have not observed increased cancer rates. The independent evidence base is insufficient to confirm or rule out long-term risks. It is not FDA-approved. Research-grade purity and sterility should be confirmed before any research use.
Preliminary
Most evidence comes from preclinical studies and case reports. Human data is limited and more research is needed.
Published Research Ranges
5–20mg daily cycles in published Russian research
Research Context Only: These are ranges reported in published scientific studies for educational reference. They are not dosing recommendations. This is not medical advice. Always consult a qualified healthcare professional.
Sources listed here are from the platform research library. All links open the original publication. No citations are generated by AI.
Effects of Epithalon on the Lifespan and Tumor Incidence in Aging Mice
Chronic Stress and Oxidative Stress as Common Factors of the Pathogenesis of Depression and Alzheimer's Disease: The Role of Antioxidants in Prevention and Treatment
Aging of lymphoid organs: Can photobiomodulation reverse age-associated thymic involution via stimulation of extrapineal melatonin synthesis and bone marrow stem cells?
Research Education Only: This profile is for educational purposes only. All information is sourced from published scientific literature. This is not medical advice. Not for human consumption. Consult qualified medical professionals for any health decisions.
We use cookies to enhance your research experience and analyze platform usage. By continuing, you agree to our Cookie Policy.